关注
Maddalena Milazzo
Maddalena Milazzo
CRBA Center for Applied Biomedical Research, University Hospital S.Orsola-Malpighi, Bologna
在 aosp.bo.it 的电子邮件经过验证
标题
引用次数
年份
1043 IN HEPATOCELLULAR CARCINOMA miR-494 IS REGULATED BY EPIGENETIC MECHANISMS AND TARGETS p27, PTEN AND PUMA
F Fornari, M Milazzo, E Callegari, M Negrini, M Galassi, S Marinelli, ...
Journal of Hepatology, S428-S429, 2013
2013
1074 EVALUATION OF EFFICACY OF ANTIANGIOGENIC TREATMENT IN A MURINE MODEL OF HEPATOCELLULAR CARCINOMA UNDER DIFFERENT TREATMENT SCHEDULES
V Salvatore, S Marinelli, MB Toaldo, M Milazzo, L Croci, L Venerandi, ...
Journal of Hepatology, S440, 2013
2013
271 MIR-221/MDM2/P53 CONTROL LOOP SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO ANTI-CANCER TREATMENTS
F Fornari, M Milazzo, C Giovannini, M Galassi, M Negrini, L Gramantieri, ...
Journal of Hepatology, S113, 2012
22012
292 IN HEPATOCELLULAR CARCINOMA MIR-519D IS UPREGULATED BY P53 AND DNA HYPOMETHYLATION
M Milazzo, F Fornari, M Galassi, M Negrini, L Gramantieri, L Bolondi
Journal of Hepatology, S120-S121, 2012
2012
34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT
F Fornari, L Gramantieri, M Milazzo, D Pollutri, GL Grazi, M Negrini, ...
Digestive and Liver Disease, S14, 2010
2010
933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT
F Fornari, L Gramantieri, M Milazzo, D Pollutri, GL Grazi, M Negrini, ...
Journal of Hepatology, S361-S362, 2010
2010
A geroscience approach for Parkinson’s disease: Conceptual framework and design of PROPAG-AGEING project
C Pirazzini, T Azevedo, L Baldelli, A Bartoletti-Stella, ...
Mechanisms of Ageing and Development 194, 111426, 2021
172021
A targeted epigenetic clock for the prediction of biological age
N Gensous, C Sala, C Pirazzini, F Ravaioli, M Milazzo, KM Kwiatkowska, ...
Cells 11 (24), 4044, 2022
142022
Age-related DNA methylation changes are sex-specific: a comprehensive assessment
I Yusipov, MG Bacalini, A Kalyakulina, M Krivonosov, C Pirazzini, ...
Aging (Albany NY) 12 (23), 24057, 2020
702020
Anti-tumor activity of a miR-199-dependent oncolytic adenovirus
E Callegari, BK Elamin, L D’Abundo, S Falzoni, G Donvito, F Moshiri, ...
PloS one 8 (9), e73964, 2013
692013
Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma
F Fornari, M Milazzo, C Patrizi, E Callegari, S Sabbioni, M Negrini, ...
Digestive and Liver Disease 46, e6, 2014
2014
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, identify cirrhotic patients with HCC
F Fornari, M Ferracin, D Trerè, M Milazzo, S Marinelli, M Galassi, ...
PloS one 10 (10), e0141448, 2015
1432015
Complex sex-specific age-related changes in DNA methylation including variability, epimutations and entropy
I Yusipov, MG Bacalini, A Kalyakulina, M Krivonosov, C Pirazzini, ...
bioRxiv, 2020.01. 15.905224, 2020
12020
Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma
E Strocchi, F Fornari, M Minguzzi, L Gramantieri, M Milazzo, V Rebuttini, ...
European journal of medicinal chemistry 48, 391-401, 2012
392012
Design, Synthesis and Biological Evaluation of Pyrazole derivatives as Potential multikinase Inhibitors in Hepatocarcinoma.
F Fornari, M Minguzzi, E Strocchi, E Locatelli, L Gramantieri, M Milazzo, ...
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 48, 391-401, 2012
2012
Early prediction of treatment response to sorafenib with elastosonography in a mice xenograft model of hepatocellular carcinoma: a proof-of-concept study
V Salvatore, MB Toaldo, S Marinelli, M Milazzo, C Palama, L Venerandi, ...
Ultraschall in der Medizin-European Journal of Ultrasound, 541-549, 2013
112013
Evaluation of efficacy of antiangiogenic treatment using US-based techniques in a murine model of hepatocellular carcinoma (HCC) under different treatment schedule
S Marinelli, V Salvatore, MB Toaldo, M Milazzo, L Croci, L Venerandi, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (S 01), WS_SL3_03, 2013
12013
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma
S Marinelli, V Salvatore, MB Toaldo, M Milazzo, L Croci, L Venerandi, ...
BMC cancer 14, 1-9, 2014
112014
F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA
F Fornari, M Milazzo, E Callegari, M Negrini, S Sabbioni, M Galassi, ...
Digestive and Liver Disease, S47, 2013
2013
F-56 Evaluation of efficacy of antiangiogenic treatment in a murine model of hepatocellular carcinoma under different treatment schedules
V Salvatore, S Marinelli, MB Toaldo, M Milazzo, L Croci, L Venerandi, ...
Digestive and Liver Disease 45, S48, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–20